Search results for: 'gene'

03 Oct 2022  |  Global  |  Market Research

Global Prenatal Genetic Testing—Forecast to 2026

Innovation Culture in Screening Drives Prenatal Genetic Testing Growth and Makes it Accessible to More Patients

Infographics

×

New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, augment the efficiency and reliability of testing, and streamline workflow. The study will help...

23 Oct 2020  |  Global  |  Market Research

Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

Infographics

×

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

In this research service, Frost & Sullivan reviews the increasing need for services in light of the growing generators demand from the commercial and the industrial sectors. The study also examines market drivers and restraints for the next 10 years. The rising need for power, along with growing customer awareness of the benefits of digital solutio...

17 Nov 2020  |  Global  |  Market Research

Innovative Business Models Emerging from Digitalization in Generators, Global, 2020

Enhanced Customer Experience through Digital Energy Transformation Creating Growth Opportunities

Infographics

×

Key Benefits

Investment in digital technologies is booming across all industries, including power generation. This research aims to identify the generators industrys current use and future decision-making trends toward digital transformation. A recent Frost & Sullivan study found that 99% of businesses are at a particular digital transformation stage. Technolo...

14 Mar 2022  |  North America  |  Market Outlook

Next-generation Diagnostics Outlook, 2022

Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

Infographics

×

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

04 May 2021  |  North America  |  Market Research

The Digital Transformation is Powering the North American Generator Sets Market

Increased Focus on Value Addition Related to System Flexibility and Digital Product Offerings; the Aim is to Gain a Competitive Advantage to Benchmark Future Growth Potential

Infographics

×

In this research service, Frost & Sullivan reviews the rising need for generator sets in light of the growing demand for power. Rising customer awareness has also opened up opportunities for diesel and gas generators over the past 10 years. In addition, the growing adoption of digital solutions for resource management, remote monitoring, and asset ...

5G represents a fundamental shift in communication network architectures that will accelerate revenue generation through innovative services facilitated via 5G-enabled smartphones, tablets, laptops, and Internet of Things (IoT) devices. It will deliver a potent combination of network capabilities and flexible options for network deployments, servic...

The COVID-19 pandemic led to the rapid scaling up of production activities in the pharmaceutical industry. An increase in the number of FDA approvals in biologics has further accelerated biopharmaceutical production, particularly in North America and Asia. With a boom in biopharmaceuticals anticipated in the next 5 to 7 years, the demand for single...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...